HRT users told to discuss breast cancer risk with GP
MHRA says discussion should take place at next GP appointment after study shows persistent raised risk of breast cancer after HRT use Related items fromOnMedica Breast cancer rate falls with decline in HRT use New breast cancer drug ‘unaffordable’ for NHS NICE rejects breast cancer drug for NHS funding Withdrawn valsartan meds not linked to short-term cancer risk Data don ’t support HRT for chronic disease prevention
Source: OnMedica Latest News - Category: UK Health Source Type: news
More News: Breast Cancer | Cancer | Cancer & Oncology | Diovan | Funding | National Institute for Health and Clinical Excelle | Study | UK Health